|
|
 |
June 26, 2008 |
Now Available:
Watch video podcasts of the 2008 EULAR press conferences
Musculoskeletal Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts.
With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.
MSK Video Report:
Paul Emery, MD presents "Tocilizumab significantly improves disease outcomes in patients with rheumatoid arthritis whose anti-TNF therapy failed: The Radiate Study" at the 2008 EULAR Congress
EULAR 2008: Steroids Injections May Prevent Rheumatoid Arthrits From Developing
A 3-week course of IM steroids may stop the progression of early rheumatoid arthritis...
ENDO 2008: More Zoledronic Acid Fracture Reduction Data Reported at Endocrine Society Meeting
Yearly infusions of zoledronic acid 5 mg reduced fractures and increased bone mineral density (BMD) when administered with or without concomitant osteoporosis therapy...
Arthritis: New ACR Guidelines Help Clinicians Incorporate Biologics Into RA Treatment Plans
The new American College of Rheumatology guidelines help rheumatologists to choose the right drugs and to monitor RA patients for untoward effects, but the guidelines should not replace sound clinical judgment...
BioPharm Business: Otsuka, UCB to Codevelop and Copromote Cimzia in Japan for Crohn's Disease
UCB and Otsuka Pharmaceuticals have agreed to copromote UCB's anti-TNFα drug Cimzia for the treatment of Crohn's Disease in Japan, the second largest pharmaceutical market in the world...
BioPharm Business: Genmab, GSK to Initiate Phase I/II Clinical Trial of Ofatumumab in Subcutaneous Study in RA
A phase I/II study will be initiated soon to evaluate a subcutaneous route of administration of ofatumumab (HuMax-CD20) in rheumatoid arthritis (RA) patients, stable on methotrexate (MTX)...